News from Amgen Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jun 02, 2014, 07:44 ET Amgen Presents New Data On Talimogene Laherparepvec As Single Agent And Combination Therapy In Metastatic Melanoma At ASCO

 Amgen (NASDAQ: AMGN) today announced new data from two key clinical trials that support the potential of talimogene laherparepvec, a novel,...


Jun 01, 2010, 18:10 ET FDA Approves Amgen's Prolia(TM) (Denosumab) for Treatment of Postmenopausal Women With Osteoporosis at High Risk for Fracture

Amgen Inc. (Nasdaq: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the...


May 14, 2010, 16:03 ET Amgen Submits Denosumab Biologics License Application to FDA for the Reduction of Skeletal Related Events in Cancer Patients

Amgen Inc. (Nasdaq: AMGN) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug...


Oct 19, 2009, 08:00 ET Amgen Provides Update on Status of Prolia(TM) (Denosumab) Biologics License Application (BLA) Submitted to the U.S. Food and Drug Administration (FDA)

Amgen Inc. (Nasdaq: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the...


Sep 13, 2009, 14:47 ET Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Osteoporosis

Amgen Inc. (Nasdaq: AMGN) today announced the presentation of data highlighting the links between medication satisfaction, adherence to...


Sep 02, 2009, 12:00 ET Tim Gunn Hosts Addressing Psoriasis(TM) Fashion Show to Raise Awareness of Psoriasis

Today, Tim Gunn, television host and fashion consultant ("Project Runway," "Tim Gunn's Guide to Style") and chief creative officer of...


Aug 13, 2009, 18:37 ET Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting

Amgen Inc. (Nasdaq: AMGN) issued the following statement on the outcome of today's meeting with the U.S. Food and Drug Administration (FDA)...


Aug 13, 2009, 07:52 ET Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs

Amgen Inc. (Nasdaq: AMGN) today will summarize data from the submitted Biologic License Applications (BLAs) for denosumab for the prevention...


Aug 11, 2009, 10:05 ET Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss

Amgen Inc. (Nasdaq: AMGN) today announced the publication of results from two pivotal Phase 3 studies investigating the safety and...


Jun 22, 2009, 15:29 ET Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August

Advisory Committee to Review Denosumab Data Amgen Inc. (Nasdaq: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has asked...


Mar 23, 2004, 00:00 ET Amgen's First Research and Development Day Highlighted 24 of the Approximately 40 Programs in its Pipeline

NEW YORK, March 23 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN), the world's largest biotechnology company, today held its first-ever...


Mar 10, 2004, 00:00 ET Frank Herringer Nominated for Amgen Board of Directors

THOUSAND OAKS, Calif., March 10 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN), the world's largest biotechnology company, today announced...


Mar 09, 2004, 00:00 ET Leonard Schaeffer Joins Amgen's Board of Directors

THOUSAND OAKS, Calif., March 9 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN), the world's largest biotechnology company, today announced...


Mar 08, 2004, 00:00 ET FDA Approves Innovative, First-In-Class Treatment for a Serious Complication of Chronic Kidney Disease

THOUSAND OAKS, Calif., March 8 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN), the world's largest biotechnology company, today announced...


Feb 25, 2004, 00:00 ET Amgen Opens State-of-the-Art Biotechnology Research Campus

SEATTLE, Feb. 25 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN), the world's largest biotechnology company, today announced the official...


Feb 23, 2004, 00:00 ET Amgen Announces Webcast of R&D Day With the Investment Community

THOUSAND OAKS, Calif., Feb. 23 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN), the world's largest biotechnology company, today announced...


Jan 22, 2004, 00:00 ET Amgen's Fourth Quarter 2003 Adjusted Earnings Per Share Increased 31 Percent to 46 Cents; Full Year 2003 Adjusted Earnings Per Share Increased 37 Percent to $1.90

THOUSAND OAKS, Calif., Jan. 22 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN), the world's largest biotechnology company, today announced...


Jan 14, 2004, 00:00 ET Amgen Announces Webcast of Fourth Quarter and Full Year 2003 Financial Results

THOUSAND OAKS, Calif., Jan. 14 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN), the world's largest biotechnology company, today announced...


Jan 13, 2004, 00:00 ET Amgen Names David J. Scott Senior Vice President, General Counsel and Secretary

THOUSAND OAKS, Calif., Jan. 13 /PRNewswire/ -- Amgen Inc. (Nasdaq: AMGN), the world's largest biotechnology company, today announced that David...


Dec 29, 2003, 00:00 ET Amgen Named One of Fortune Magazine's '100 Best Companies to Work For'

THOUSAND OAKS, Calif., Dec. 29 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN), the world's largest biotechnology company, today announced...


Dec 15, 2003, 00:00 ET Amgen Forecasts Strong 2004 Financial Performance

THOUSAND OAKS, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN), the world's largest biotechnology company, today provided...


Dec 09, 2003, 00:00 ET Amgen Names David Beier Senior Vice President, Global Government Affairs

THOUSAND OAKS, Calif., Dec. 9 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN), the world's largest biotechnology company, today announced...


Nov 11, 2003, 00:00 ET Amgen Announces Plans for Epratuzumab

THOUSAND OAKS, Calif., Nov. 11 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today announced its decision not to commence a registration...


Oct 23, 2003, 01:00 ET Science Recognizes Amgen as a Top Employer in Annual Survey

THOUSAND OAKS, Calif., Oct. 23 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN), the world's largest biotechnology company, has been named...


Oct 21, 2003, 01:00 ET Amgen's Third Quarter 2003 Adjusted Earnings Per Share Increases 56% to 53 Cents

THOUSAND OAKS, Calif., Oct. 21 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today announced that adjusted earnings per share for the...